跳至主要内容
临床试验/JPRN-UMIN000030101
JPRN-UMIN000030101招募中未知

The study of gene and epigenetic modifications, bioelement and physical active substance on the patients with neurodegenerative diseases. - The study of gene and epigenetic modifications, bioelement and physical active substance on the patients with neurodegenerative diseases.

Gifu Pharmaceutical University0 个研究点目标入组 100 人开始时间: 2017年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • <Amyotrophic lateral sclerosis (ALS)> Exclude the following diseases. Other motor neuron disorders, motor neurophathy, cervical spondylosis, and inflammatory myopathy such as inclusion body myositis. <Idiopathic basal ganglia calcification (IBGC)> To exclude diseases which show calcification, because of some causes such as hypoparathyroism, pseudo hypoparathyroism, pseudopseudo hypoparathyroism (Albright's osteodystrophy), Down syndrome, collagen diseases, angiitis, infections, intoxication, trauma, radiation therapy and so on.

研究者

相似试验